Investor Relations

BOSTON--(BW HealthWire)--Feb. 14, 2001--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will file a registration statement with the Securities and Exchange Commission on February 15, 2001 for a proposed underwritten offering of 7,000,000 shares of its common stock. The company will sell 3,500,000 shares and selling shareholders will sell the remaining 3,500,000.

This release is not an offer to sell or a solicitation of an offer to buy any of these securities.

--30--kk/ny*